Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells

Carcinogenesis

Volumn 28, Issue 12, 2007, Pages 2624-2631

  Cheung, Ronald S Y ^a   Brooling, John T ^a   Johnson, Melissa M ^a   Riehle, Kimberly J ^a,b   Campbell, Jean S ^a   Fausto, Nelson ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE DISRUPTION; GENE FUNCTION; GENE OVEREXPRESSION; INOCULATION; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MALE; MITOGENICITY; NONHUMAN; NUDE MOUSE; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; STEM CELL; TRANSGENIC MOUSE; TUMOR DIFFERENTIATION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MUTATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; RATS; STEM CELLS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 36949025308     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm184     Document Type: Article

References (52)

1. Dang,C.V. (1999) c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol., 19, 1-11.
2. Grandori,C. et al. (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699.
3. Fabregat,I. et al. (2007) Survival and apoptosis: A dysregulated balance in liver cancer. Liver Int., 27, 155-162.
4. Hoffman,B. et al. (1998) The proto-oncogene c-myc and apoptosis. Oncogene, 17, 3351-3357.
5. Obaya,A.J. et al. (1999) Mysterious liaisons: The relationship between c-Myc and the cell cycle. Oncogene, 18, 2934-2941.
6. Evan,G. et al. (1998) A matter of life and cell death. Science 281, 1317-1322.
7. Eischen,C.M. et al. (1999) Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev., 13, 2658-2669.
8. Eischen,C.M. et al. (2001) Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol. Cell. Biol., 21, 5063-5070.
9. Ikeguchi,M. et al. (2004) Expression of c-myc mRNA in hepatocellular carcinomas, noncancerous livers, and normal livers. Pathobiology, 71, 281-286.
10. Murakami,H. et al. (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic neogenesis. Cancer Res., 53, 1719-1723.
11. Calvisi,D.F. et al. (2005) Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer. Toxicol. Pathol., 33, 181-184.
12. CavinL.G. et al. (2005) Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas. Mol. Cancer Res., 3, 403-412.
13. Santoni-Rugiu,E. et al. (1998) Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res., 58, 123-134.
14. DuHadaway,J.B. et al. (2001) Bin1 mediates apoptosis by c-Myc in transformed primary cells. Cancer Res., 61, 3151-3156.
15. Morrish,F. et al. (2003) c-MYC apoptotic function is mediated by NRF-1 target genes. Genes Dev., 17, 240-255.
16. Hoang,A.T. et al. (1995) A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol. Cell. Biol., 15, 4031-4042.
17. Conzen,S.D. et al. (2000) Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol. Cell. Biol., 20, 6008-6018.
18. Chang,D.W. et al. (2000) The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol. Cell. Biol., 20, 4309-4319.
19. Herbst,A. et al. (2005) A conserved element in Myc that negatively regulates its proapoptotic activity. EMBO Rep., 6, 177-183.
20. Fausto,N. (1990) Oval cells and liver carcinogenesis: An analysis of cell lineages in hepatic tumors using oncogene transfection techniques. Prog. Clin. Biol. Res., 331, 325-334.
21. Fausto,N. (2004) Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells. Hepatology, 39, 1477-1487.
22. Hooth,M.J. et al. (1998) Spontaneous neoplastic transformation of WBF344 rat liver epithelial cells. Am J. Pathol., 153, 1913-1921.
23. Roskams,T.A. et al. (2003) Progenitor cells in diseased human liver. Semin. Liver Dis., 23, 385-396.
24. Roskams,T. (2003) Progenitor cell involvement in cirrhotic human liver diseases: From controversy to consensus. J. Hepatol., 39, 431-434.
25. Sell,S. (2002) Cellular origin of hepatocellular carcinomas. Semin. Cell Dev. Biol., 13, 419-424.
26. Lazaro,C.A. et al. (1998) Generation of hepatocytes, from oval cell precursors in culture. Cancer Res., 58, 5514-5522.
27. Evarts,R.P. et al. (1989) In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res., 49, 1541-4547.
28. Goyette,M. et al. (1990) Expression of hepatocyte and oval cell antigens in hepatocellular carcinomas produced by oncogene-transfected liver epithelial cells. Cancer Res., 50, 4809-4817.
29. Braun,L. et al. (1989) Production of hepatocellular carcinoma by oval cells: Cell cycle expression of c-myc and p53 at different stages of oval cell transformation. Cancer Res., 49, 1554-1561.
30. Yaswen,P. et al. (1984) Isolation of oval cells by centrifugal elutriation and comparison with other cell types purified from normal and preneoplastic livers. Cancer Res., 44, 324-331.
31. Argast,G.M. et al. (2004) Epidermal growth factor receptor transactivation mediates tumor necrosis factor-induced hepatocyte replication. J. Biol. Chem., 279, 34530-34536.
32. Brooling,J.T. et al. (2005) Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology, 41, 906-915.
33. Borrell-Pages,M. et al. (2003) TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J., 22, 1114-1124.
34. Magid,R. et al. (2003) Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of c-Myc. J. Biol. Chem., 278, 32994-32999.
35. Leone,G. et al. (1997) Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature, 387, 422-426.
36. Perez-Roger,I. et al. (1997) Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes. Oncogene, 14 2373-2381.
37. Evan,G.I. et al. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
38. Nilsson.J.A. et al. (2003) Myc pathways provoking cell suicide and cancer. Oncogene, 22, 9007-9021.
39. Strasser,A. et al. (1990) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bc1-2. Nature, 348, 331-333.
40. Factor,V.M. et al. (1998) Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic-mouse model of accelerated hepatocarcinogenesis. J. Biol. Chem., 273, 15846-15853.
41. Factor,V. et al. (2001) Roles of Akt/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor a1pha/c-myc transgenic mice. Hepatology 34, 32-41.
42. Alison,M.R. et al. (2005) Liver cancer: The role of stem cells. Cell Prolif., 38, 407-421.
43. Santiago-Josefat,B. et al. (2007) Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors. J. Biol. Chem., 282, 8325-8331.
44. Hemann,M.T. et al. (2005) Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature, 436, 807-811.
45. Salghetti,S.E. et al. (1999) Destruction of Myc by ubiquitin-mediated proteolysis: Cancer-associated and transforming mutations stabilize Myc. EMBO J., 18, 717-726.
46. Welcker,M. et al. (2004) The Fbw7 tumór suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc. Natl Acad. Sci. USA, 101, 9085-9090.
47. Noguchi,K. et al. (1999) Regulation of c-Myc through phosphorylation. at Ser-62 and Ser-71 by c-Jun N-terminal kinase. J. Biol. Chem,, 274, 32580-32S87.
48. Watnick,R.S. et al. (2003) Ras modulates Myc activity to repress thrombo-spondin-1 expression and increase tumor angiogenesis. Cancer Cell, 3, 219-231.
49. Bhatia K. et al. (1993) Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat. Genet., 5, 56-61.
50. Bhatia,K. et al. (1994) Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood, 84, 883-888.
51. l Clark,H.M. et al. (1994) Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. Cancer Res., 54, 3383-3386.
52. Yano,T. et al. (1993) Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene, 8, 2741-2748.